ProShares Ultra Nasdaq Biotechnology
CThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.
$103.59−5.20 (−4.78%)
- 1.19%
- $91M
- +70.9%
- 0.21%
- 0M sh
- $108.80
- low $62.72high $126.40
The ETF.net BIB Grade
C
Score 54 out of 100
- 21 of 99
Score 54 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.D32 out of 100Rank 66 of 99Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.B66 out of 100Rank 19 of 96Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.A82 out of 100Rank 7 of 99Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.B56 out of 100Rank 11 of 23Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.A75 out of 100Rank 11 of 99
Our read on BIB
CBiotech with the volume turned up. BIB aims for twice the daily move of the Nasdaq Biotechnology Index, about 300 drug and gene names deep, and has run that playbook since 2010. The daily reset means holding period is the whole game.
The Fund seeks daily investment results, before fees and expenses, that correspond to two times the daily performance of the Nasdaq Biotechnology Index.
Why people hold it
- Twice the daily move of the Nasdaq Biotechnology Index, spread across roughly 300 biotech and pharma names instead of one binary trial readout.
- Two times daily, not three: a lower gear than the 3x products that crowd the leveraged shelf.
- Launched in 2010, a long run for a geared fund and one of the older ways to trade biotech with leverage.
- Lands in the upper half of its leveraged-bull peer group, helped by a milder risk profile than most funds carrying daily gearing.
Worth knowing
- Daily reset: the 2x target applies to one day at a time. Over longer holds, compounding can pull results away from twice the index's cumulative move, especially in choppy markets.
- 1.19% a year, above the typical leveraged fund's fee, and the drag compounds the longer the position sits.
- Trades thinly next to marquee geared names like QLD and FAS, so spreads and limit orders carry more weight here.
BIB Holdings
- Stocks
- 247
- 64%
- Net Other Assets (Liabilities)
Sectors
- Health Care75.3%
- Financials24.7%
Geography
- United States91.60%
- United Kingdom1.81%
- Netherlands1.49%
- Ireland1.17%
- Switzerland0.94%
- Denmark0.91%
- France0.70%
- Germany0.57%
- 0.81%
BIB Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
BIB$17,085
Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | BIB |
|---|---|
| Year to date | +36.5% |
| 1 month | −0.8% |
| 3 months | +5.8% |
| 1 year | +70.9% |
| 3 years | +33.4% |
| 5 years | +5.0% |
| 10 years | +10.3% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | BIB |
|---|---|---|
| 2026 YTD | +36.5% | |
| 2025 | +59.2% | |
| 2024 | −9.8% | |
| 2023 | −1.1% | |
| 2022 | −28.8% | |
| 2021 | −6.0% | |
| 2020 | +39.8% |
BIB in the news
BIB Dividends
- 0.21%
- $0.22
- $0.08 per share
- Twice a year
Distribution history
BIB Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 35.3%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.90
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −61.8%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.20
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
BIB Cost
1.19%
BIB1.19%
- The middle half of Leveraged Long (2x & Other) funds
- Median 1.00%
66 of the 95 Leveraged Long (2x & Other) funds charge less.
Other funds in Leveraged Long (2x & Other)
- BGLDWRoundhill Investments - Gold WeeklyPay ETFExpense ratio 0.99%1 year return —
- BQQQUDirexion Daily Magnificent 7 Bull 2X ETFExpense ratio 1.00%1 year return +31.1%
- CUREProShares Ultra Real EstateExpense ratio 1.10%1 year return +5.2%
- CJNUGDirexion Daily Junior Gold Miners Index Bull 2X ETFExpense ratio 1.03%1 year return −9.8%
- CAIBUDirexion Daily AI and Big Data Bull 2X ETFExpense ratio 1.05%1 year return +35.2%